Saloni Shirke
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Larkin Community Hospital (2020–2021); Bristol Hospital (2022)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Saloni Shirke's research has focused on a range of medical topics, including infectious diseases, critical care, and the application of advanced medical technologies. Shirke has contributed to systematic reviews and meta-analyses examining the efficacy of treatments for severe COVID-19, such as the interleukin-1 antagonist anakinra. Additionally, Shirke has investigated specific clinical cases, including subarachnoid hemorrhage in patients with HIV and endocarditis, and rare complications like mycotic pseudoaneurysms following Salmonella gastroenteritis. The researcher has also explored potential prophylactic measures, such as intravenous ozonized saline therapy for healthcare workers during the COVID-19 pandemic. Shirke's work also touches upon emerging technologies like digital twins, with applications across various industries including healthcare.
Metrics
- h-index: 3
- Publications: 9
- Citations: 35
Selected Publications
-
Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report. (2025)
-
Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis (2025)
Collaboration Network
Top Collaborators
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
- Efficacy of 20-valent pneumococcal vaccination in chemotherapy patients: A first real world report.
Similar Researchers
Based on overlapping research topics